Real-World Effectiveness of Intravitreal Dexamethasone Implants - Comparison between Eyes Eligible and Ineligible for Clinical Trials and Their Associated Outcomes.

[1]  Chi-Chun Lai,et al.  Comparison of Sodium-Glucose Cotransporter 2 Inhibitors vs Glucagonlike Peptide-1 Receptor Agonists and Incidence of Dry Eye Disease in Patients With Type 2 Diabetes in Taiwan , 2022, JAMA network open.

[2]  S. Shao,et al.  Validation of Diagnostic Codes to Identify Carbon Monoxide Poisoning in Taiwan’s Claims Data , 2022, Frontiers in Pharmacology.

[3]  Swu-Jane Lin,et al.  Positive Predictive Value of ICD-10 Codes for Cerebral Venous Sinus Thrombosis in Taiwan’s National Health Insurance Claims Database , 2022, Clinical epidemiology.

[4]  Chi-Chun Lai,et al.  Association between Sodium Glucose Co-transporter 2 Inhibitors and Incident Glaucoma in Patients with Type 2 Diabetes: A Multi-institutional Cohort Study in Taiwan. , 2022, Diabetes & metabolism.

[5]  Y. Huang,et al.  Discharge status validation of the Chang Gung Research database in Taiwan , 2021, Biomedical journal.

[6]  J. Rodrigues,et al.  Dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema: real-world data versus clinical trials outcomes. , 2021, International journal of ophthalmology.

[7]  S. Garg,et al.  Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis , 2021, Journal of clinical medicine.

[8]  Chi-Chun Lai,et al.  Risk of diabetic macular oedema with sodium‐glucose cotransporter‐2 inhibitors in type 2 diabetes patients: A multi‐institutional cohort study in Taiwan , 2021, Diabetes, obesity & metabolism.

[9]  C. Lange,et al.  Real-life medium term follow-up data for intravitreal dexamethasone implant in retinal vein occlusion , 2021, Scientific Reports.

[10]  R. Gallemore,et al.  Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review , 2020, Clinical ophthalmology.

[11]  Mário Ornelas,et al.  Macular edema secondary to retinal vein occlusion in a real-life setting: a multicenter, nationwide, 3-year follow-up study , 2020, Graefe's Archive for Clinical and Experimental Ophthalmology.

[12]  Shu Yang,et al.  Improving trial generalizability using observational studies , 2020, Biometrics.

[13]  A. Pottegård,et al.  Differences Between Randomized Clinical Trial Participants and Real-World Empagliflozin Users and the Changes in Their Glycated Hemoglobin Levels. , 2020, JAMA network open.

[14]  E. Lai,et al.  Sodium glucose co-transporter 2 inhibitors and cardiovascular event protections: how applicable are clinical trials and observational studies to real-world patients? , 2019, BMJ Open Diabetes Research & Care.

[15]  P. Lu,et al.  Association of glaucoma with risk of retinal vein occlusion: A meta‐analysis , 2019, Acta ophthalmologica.

[16]  S. Sivaprasad,et al.  A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: The European DME Registry Study. , 2019, Ophthalmology.

[17]  E. Lai,et al.  Comparative risk evaluation for cardiovascular events associated with dapagliflozin vs. empagliflozin in real-world type 2 diabetes patients: a multi-institutional cohort study , 2019, Cardiovascular Diabetology.

[18]  D. Webb,et al.  Pharmacoepidemiology: Using randomised control trials and observational studies in clinical decision‐making , 2019, British journal of clinical pharmacology.

[19]  P. Campochiaro,et al.  Loss of Peak Vision in Retinal Vein Occlusion Patients Treated for Macular Edema. , 2019, American journal of ophthalmology.

[20]  Y. Kao Yang,et al.  The Chang Gung Research Database—A multi‐institutional electronic medical records database for real‐world epidemiological studies in Taiwan , 2019, Pharmacoepidemiology and drug safety.

[21]  J. Garcia-Arumi,et al.  Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world , 2019, PloS one.

[22]  C. Kim,et al.  Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients , 2018, British Journal of Ophthalmology.

[23]  M. Maia,et al.  Effectiveness and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: A Real-World Experience , 2018, Ophthalmologica.

[24]  U. Schmidt-Erfurth,et al.  Correlation of Central Retinal Thickness and Visual Acuity in Diabetic Macular Edema. , 2018, JAMA ophthalmology.

[25]  A. Mansour,et al.  Long-term visual outcome and its predictors in macular oedema secondary to retinal vein occlusion treated with dexamethasone implant , 2018, British Journal of Ophthalmology.

[26]  A. Capone,et al.  Real-World Assessment of Dexamethasone Intravitreal Implant in DME: Findings of the Prospective, Multicenter REINFORCE Study. , 2018, Ophthalmic surgery, lasers & imaging retina.

[27]  M. Larsen,et al.  Diabetic macular oedema treated with intravitreal anti‐vascular endothelial growth factor – 2–4 years follow‐up of visual acuity and retinal thickness in 566 patients following Danish national guidelines , 2018, Acta ophthalmologica.

[28]  Mei-Ching Lee,et al.  Association of Varicose Veins With Incident Venous Thromboembolism and Peripheral Artery Disease , 2018, JAMA.

[29]  J. Chhablani,et al.  Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome. , 2017, American journal of ophthalmology.

[30]  Wen-Cheng Chen,et al.  Chang Gung Research Database: A multi-institutional database consisting of original medical records , 2017, Biomedical journal.

[31]  S. Sivaprasad,et al.  Identification of time point to best define ‘sub-optimal response’ following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data , 2017, Eye.

[32]  L. Joskowicz,et al.  Comparison of Snellen and Early Treatment Diabetic Retinopathy Study charts using a computer simulation. , 2016, International journal of ophthalmology.

[33]  S. Whitcup,et al.  Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. , 2014, Ophthalmology.

[34]  Dan Lindfield,et al.  Dexamethasone implants in retinal vein occlusion: 12-month clinical effectiveness using repeat injections as-needed , 2013, British Journal of Ophthalmology.

[35]  Pedro Romero-Aroca,et al.  Managing diabetic macular edema: The leading cause of diabetes blindness. , 2011, World journal of diabetes.

[36]  C. Lowder,et al.  Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. , 2011, Archives of ophthalmology.

[37]  M. Blumenkranz,et al.  Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. , 2010, Ophthalmology.

[38]  Peter K Kaiser,et al.  Prospective evaluation of visual acuity assessment: a comparison of snellen versus ETDRS charts in clinical practice (An AOS Thesis). , 2009, Transactions of the American Ophthalmological Society.

[39]  Ingrid U Scott,et al.  A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. , 2009, Archives of ophthalmology.

[40]  M. Gillies,et al.  Intravitreal Triamcinolone Acetonide Inhibits Breakdown of the Blood-Retinal Barrier Through Differential Regulation of VEGF-A and Its Receptors in Early Diabetic Rat Retinas , 2008, Diabetes.

[41]  Michael Bach,et al.  Visual acuities "hand motion" and "counting fingers" can be quantified with the freiburg visual acuity test. , 2006, Investigative ophthalmology & visual science.

[42]  Hiroshi Tamura,et al.  Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. , 2005, Investigative ophthalmology & visual science.

[43]  Paris G Tranos,et al.  Macular edema. , 2004, Survey of ophthalmology.